Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Cited by (863)

Items 801–863 of 863

1. Additional file 4 of MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
   Wallach, Thomas, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Christina Krüger, Paul Dembny et al. · 2021 · Figshare
2. Additional file 8 of MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
   Wallach, Thomas, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Krüger, Christina, Paul Dembny et al. · 2021 · Figshare
3. Additional file 1 of Immunotherapy with an antibody against CD1d modulates neuroinflammation in an α-synuclein transgenic model of Lewy body like disease
   Michiyo Iba, Somin Kwon, Changyoun Kim, Marcell P. Szabo, Liam Horan-Portelance, Maria D Lopez-Ocasio, Pradeep Kumar Dagur, Cassia Overk, Robert A. Rissman, Masliah, Eliezer · 2024 · Figshare
4. Additional file 3 of Neuroinflammation and protein pathology in Parkinson’s disease dementia
   Antonina Kouli, Marta Camacho, Allinson, Kieren, Caroline H. Williams‐Gray · 2020 · Figshare
5. Additional file 1 of p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease
   Chen, Jialong, Mao, Kanmin, Yu, Honglin, Wen, Yue, She, Hua, Zhang, He, Liu, Linhua, Mingque Li, Li, Wenjun, Zou, Fei · 2021 · Figshare
6. Additional file 11 of MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
   Wallach, Thomas, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Christina Krüger, Paul Dembny et al. · 2021 · Figshare
7. Additional file 5 of p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease
   Chen, Jialong, Mao, Kanmin, Yu, Honglin, Wen, Yue, She, Hua, Zhang, He, Liu, Linhua, Mingque Li, Li, Wenjun, Zou, Fei · 2021 · Figshare
8. Additional file 1 of Alpha-synuclein activates the classical complement pathway and mediates complement-dependent cell toxicity
   Emil Gregersen, Cristine Betzer, Kim, Woojin S., Gergő E. Kovács, Lasse Reimer, Glenda M. Halliday, Steffen Thiel, Jensen, Poul Henning · 2021 · Figshare
9. Additional file 4 of Neuroinflammation and protein pathology in Parkinson’s disease dementia
   Antonina Kouli, Marta Camacho, Allinson, Kieren, Caroline H. Williams‐Gray · 2020 · Figshare
10. Additional file 3 of p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease
    Chen, Jialong, Mao, Kanmin, Yu, Honglin, Wen, Yue, She, Hua, Zhang, He, Liu, Linhua, Mingque Li, Li, Wenjun, Zou, Fei · 2021 · Figshare
11. Additional file 13 of MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
    Wallach, Thomas, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Christina Krüger, Paul Dembny et al. · 2021 · Figshare
12. Additional file 6 of MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
    Wallach, Thomas, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Christina Krüger, Paul Dembny et al. · 2021 · Figshare
13. Additional file 4 of p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease
    Chen, Jialong, Mao, Kanmin, Yu, Honglin, Wen, Yue, She, Hua, Zhang, He, Liu, Linhua, Mingque Li, Li, Wenjun, Zou, Fei · 2021 · Figshare
14. Additional file 1 of MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
    Wallach, Thomas, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Christina Krüger, Paul Dembny et al. · 2021 · Figshare
15. Additional file 10 of MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
    Wallach, Thomas, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Krüger, Christina, Paul Dembny et al. · 2021 · Figshare
16. Additional file 9 of MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
    Wallach, Thomas, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Krüger, Christina, Paul Dembny et al. · 2021 · Figshare
17. Immunomodulatory effects of anesthetic drugs and their implications in neurodegenerative disease progression
    Mohammed Hadi Kadhim Al-Juhaishi, Nooralhuda Mohammed Hadi Al-Juhaishi, Ahmed Mohammed Hadi Al-Juhaishi · 2024 · Neurophysiology
18. Ultrasonic repression of TRPA1-dependent astrocyte reactivity confers neuroprotection in models of Lewy body dementia
    Ji Young Kim, Keunhyung Lee, Minseok Koo, Doeun Kim, Jin Kyung Hong, Jeong-Yun Choi, Han Seok Ko, Joo-Ho Shin, Joo Min Park, Jinhyoung Park et al. · 2026 · Translational Neurodegeneration
19. Animal and Cell Models in Alzheimer’s and Parkinson’s Disease: Current Innovations Reviewed
    Christopher Rejitha, Lavanya Babu · 2026 · Current Aging Science
20. A new therapeutic approach for Parkinson’s disease: dual targeting of α-Synuclein aggregation and microglial function by the novel immunomodulator 3-Monothiopomalidomide
    Maria Francesca Palmas, Khosro Aminzadeh, Matteo Runfola, Pathik Parekh, Clara Porcedda, David Tweedie, Luca Casula, Maria Cristina Cardia, Jacopo Marongiu, Michela Etzi et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
21. Contrôle de l'activation microgliale par les lymphocytes T dans un modèle murin de neurodégénérescence induite par la 6-OHDA
    Josselin Uhlrich · 2014 · theses.fr (ABES)
22. Diversité Génétique des Molécules de Réponse Immunitaire Innée dans les Troubles Bipolaires
    José Oliveira · 2015 · theses.fr (ABES)
23. Understanding the role of perivascular macrophages in Parkinson's disease pathophysiology
    Jaime R. Fuentealba · 2017 · theses.fr (ABES)
24. Etude de la coopération de l'alpha-synucléine et de LRRK2 dans les dysfonctions mitochondriales dans la Maladie de Parkinson
    Camille Gardier · 2019 · theses.fr (ABES)
25. Evaluation of an In Situ Polymerizing Hydrogel Scaffold as a Brain Delivery System for Parkinson’s Disease therapeutics
    Francesco Gubinelli · 2019 · theses.fr (ABES)
26. Multifactorial and translational approaches for modeling synucleinopathies : mechanistic and therapeutic implications
    Marie-Laure Arotçarena · 2019 · theses.fr (ABES)
27. Étude de la composante neuroinflammatoire dans les DFT/SLA
    Julie Smeyers · 2020 · theses.fr (ABES)
28. Étude moléculaire de l'inflammation chronique dans la maladie de Parkinson
    Anne‐Claire Compagnion · 2019 · theses.fr (ABES)
29. Study of the interactions between the nervous system and the gut in Parkinson’s disease using Drosophila
    Xiaojing Yue · 2022 · theses.fr (ABES)
30. Towards the identification of targets and markers of Parkinson’s disease-associated neuroinflammation
    Cansu Yildirim-Balatan · 2021 · theses.fr (ABES)
31. Characterization and quantification of proteins involved in neurodegenerative diseases by mass spectrometry
    Kim Thanh Van · 2025 · theses.fr (ABES)
32. Angelic Acid Disassembles Fibrillar α-Synuclein Aggregates through β-Sheet Interface Disruption
    Hyo Gi Jung, Junho Bang, Juhyun Kim, Yong Wook Kim, Wonbin Moon, Hyunji Kim, Jisung Yoon, Kyo Seon Hwang, Jeong Hoon Lee, S Lee et al. · 2026 · ACS Chemical Neuroscience
33. Lysophospholipids in Synucleinopathies: A Conceptual Framework Linking Proteostasis and Neuroinflammatory Signaling
    Tamotsu Tsukahara, Hisao Haniu, Yoshikazu Matsuda · 2026 · Brain Sciences
34. Beyond the brain: a multisystem review of pathogenesis, comorbidity, and therapeutic progress in sporadic Parkinson’s disease
    Yang Li, Lijun Guo, Xiya Yu, Changgeng Peng · 2026 · Ageing and Neurodegenerative Diseases
35. Formation and toxicity of protein misfolded oligomers: Mechanistic insights and therapeutic opportunities in protein aggregation diseases
    Lorenzo Neri, Carol A. Anderson, Lucas B. Fallot, Benedetta Mannini, Ryan Limbocker · 2026 · Elsevier eBooks
36. Integration of TSPO PET and fluid biomarkers to assess neuroinflammation in Parkinson’s disease
    Skye Hsin‐Hsien Yeh, Tsung-Hsun Yu, Chia-Ju Liu, Sung‐Pin Fan, Pin‐Shiuan Chen, Cheng‐Hsuan Li, Mei‐Fang Cheng, Chin‐Hsien Lin · 2026 · European Journal of Nuclear Medicine and Molecular Imaging
37. Propagation of α-synuclein pathology: models, mechanisms and future goals
    Aryeh Zolin, Sarah A. Weber, Yan Xin Xie, Jacqueline Burré · 2026 · Molecular Neurodegeneration Advances
38. Alpha-synuclein at the crossroads of host–virus interactions: immunological roles beyond the nervous system
    Valentina Artusa, Fiona Limanaqi, Elena Santacroce, Mario Clerici, Andrea Cossarizza, Mara Biasin, Lara Gibellini, Daria Trabattoni · 2026 · Journal of Virology
39. Blood-brain barrier model architecture shapes peripheral immune cell trafficking in Parkinson’s disease
    Oceane Martinez, Lucile Gentile, Floriane Bretheau, Allison Yearwood, O.J. Arevalo, Flávia Natale Borba, Martine Boutin, Françoise Morin, Myriam Vaillancourt, Sylvie Breton et al. · 2026 · Acta Neuropathologica Communications
40. From Air to Brain: Environmental Nanoparticles as Modifiable Risk Factors for Neurodevelopmental, Neurodegenerative, and Mental Disorders
    Cristina Hermosillo‐Abundis, Óscar Arias-Carrión, Carlos César Contreras‐Ibáñez, M.A. Mendéz-Rojas · 2026 · ACS Omega
41. Spreading α-synuclein rewires organelle communication and impairs neuron–astrocyte mitochondrial quality control
    Elisabeth Fritsch, Kamelija Horvatović, Paula Santos Otte, Tomáš Koudelka, Jana Rossius, Caroline Braeuning, Laura Breimann, Ilaria Piazza, Melissa Birol · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
42. Unconventional Protein Secretion in the Central Nervous System: Mechanisms and Roles in Physiology and Disease
    Steven A. Krauklis, Sevnur Kömürlü Keceli, Edward M. Campbell, Prabhodh S. Abbineni · 2026 · Journal of Neurochemistry
43. Brain macrophages in neurodegeneration
    Rachel J. Johnston, Nicole A. Pagán Torres, Yangchen Li, Claudia Z. Han · 2026 · Advances in immunology
44. Mechanistic insights into the inhibition of α-synuclein aggregation by sugar-based nanoparticles
    Danish Alam, Tanzeel Khan, Iqra Sadiq, Priyanka Mudad, Malik Aquib Javed, Tokeer Ahmad, Asimul Islam, Meryam Sardar · 2026 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
45. Parkinson’s Disease, Microglia, and Extracellular Matrix Remodeling
    Norma Serrano‐García, Alexis Ponce-Juárez, Maximiliano Ganado, Javier Pérez-Villavicencio, Moisés Rubio‐Osornio · 2026 · Neuroglia
46. Glia-Based Early Diagnosis of Prodromal Parkinson’s Disease: From REM Sleep Behavior Disorder to Brainstem Circuit Dysfunction
    Kyungchul Noh, Sang Myun Park · 2026 · KOBRA Reports
47. Tuberculosis and Parkinson's disease: is there really a link?
    Thomas Schiestel · 2026 · Medical Hypotheses
48. Plasma α-synuclein and QSM-derived susceptibility in Parkinson’s disease: associations with clinical features
    Xingjun Li, Tianfei Luo, Jing Bai · 2026 · Frontiers in Aging Neuroscience
49. Selective Neuronal Vulnerability to Alpha-Synuclein Pathology in Parkinson’s Disease: A Critical Review of Mechanistic Rationale and Biomarker Stratification
    Livia Livinț Popa, Andreea Nicolaie, Alexandra Maștaleru, Ștefan Socolov, Mihaela Mitrea, Gabriela Popescu, Thomas Gabriel Schreiner, Roxana Ana Covali, Laura-Elena Cucu, Lucia Corina Dima-Cozma et al. · 2026 · Medical Sciences
50. Plastamination in Human Brain: The Possible Role of Microplastics in Neuroinflammation and Parkinson’s Disease
    Ezia Guatteo, Maria Zelinda Romano, Nicola Berretta, Mario Ruggiero, Antonietta Santoro, Filomena Mazzeo, Rosaria Meccariello · 2026 · Microplastics
51. Engineered α-Synuclein-specific nanobody CAR iTregs restrain neuroinflammation and proteinopathy in Parkinson’s disease mice
    Alice Calderoni, Melania Nannoni, Giorgia Ruffini, Matteo Doglio, Clara Bercher-Brayer, Serena Gea Giannelli, Ronald Melki, Monica Casucci, Chiara Bonini, Sharon Muggeo et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
52. Retromer-targeted therapy for neurodegenerative diseases
    Michele Persico, Sophronea Tuithung, Alejandra Lorenzo, Darynaisha Crawford, Simona Eleuteri, David K. Simon · 2026 · Molecular Neurodegeneration
53. Brain region-resolved pharmacodynamics of an antisense oligonucleotide targeting human SNCA 3′UTR in BAC-hSNCA rats
    Marianna Naki, Fedon-Giasin Kattan, Marina Pantazopoulou, Sissy Skea, Dimitrios Zisis, Eleftherios Pilalis, Maria Fouka, Effrosyni Koronaiou, Christos Fotis, Olaf Rieß et al. · 2026 · Translational Neurodegeneration
54. Mechanisms of Brain Aging and Their Links to Alzheimer’s and Parkinson’s Disease Pathology
    Haiyi Yi, Haimeng Qin, Jo Aan Goon, Suzana Makpol, Jen Kit Tan · 2026 · International Journal of Molecular Sciences
55. α‐Synuclein Promotes Atherosclerosis by Impairing Macrophage Autophagic Flux
    Mengting Qin, Xuying Xiang, Xiaoqing Guo, Shengnan Wang, 陈姣姣, Dailiang Jiang, Yuhang Feng, Jiangnan Yu, Ling Mao · 2026 · Aging Cell
56. Cellular and systemic modifiers of alpha-synuclein proteostasis
    Suzanne Couzijn, Anna P. Ainslie, Alejandro Herrón-Bedoya, Ellen A. A. Nollen · 2026 · Philosophical Transactions of the Royal Society B Biological Sciences
57. Human microglia clear intraneuronal α-synuclein aggregates by GPNMB-mediated trogocytosis
    Hung-Ju Chueh, Antigoni Katsikoudi, Ana Aragón-González, Chor Lai Lam, Liezel Tamon, Ashwin Jainarayanan, Devika Agarwal, Sally A. Cowley, David Sims, George K. Tofaris · 2026 · Science Translational Medicine
58. The dual immunomodulatory roles and signaling mechanisms of toll-like receptor 2 in different diseases
    Chenyu Le, Xiulin Dong, Ying Bian, Yuting Liu, Xinyi Gu, Xiaofeng Zhang, Jianfeng Yang, Lingyun Li · 2026 · Biochemical Pharmacology
59. CD38 inhibition increases neuronal survival and reduces α-synuclein in vitro, elevates brain NAD+, and reduces motor deficits in a Parkinson’s disease model
    Jenna R. M. Harvey, Thomas H. Wight, Maxine Roberts, Victoria J. Mulligan, Daniel F. Barker, Chloe Sherlock, Bernardino Ossola, Richard Hewer, Xiao Xu, Keith J. Page et al. · 2026 · Frontiers in Pharmacology
60. Microbial metabolites as modulators of gut–brain communication in neurodegeneration: from intestinal sensing to disease initiation and progression
    Xi Liu, Sirui Wang, Wei Long, Xinyue Tan, Wanlin Li, LiChen Gao · 2026 · Frontiers in Aging Neuroscience
61. BindingDB Entry 50013860: Structure based design and synthesis of novel Toll-like Receptor 2 (TLR 2) lipid antagonists.
    BindingDB · 2022 · UC San Diego
62. Immunometabolic dysregulation of reactive microglia and astrocytes in neurodegenerative diseases: Mechanistic insights and therapeutic implications
    Cheng Gao, Ran Shi, Xianliang Jiang, Hui Chai, Xiao He · 2026 · Journal of the Neurological Sciences
63. Targeting α-Synuclein as a Parkinson’s Disease Therapeutic
    Luke Esposito · 2014 · Topics in medicinal chemistry